These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8438050

  • 1. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS, Winer J, Landon DN, Stotter A, Pinching AJ.
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [Abstract] [Full Text] [Related]

  • 2. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
    Dalakas MC, Leon-Monzon ME, Bernardini I, Gahl WA, Jay CA.
    Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
    [Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A.
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [Abstract] [Full Text] [Related]

  • 4. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL.
    N Engl J Med; 1990 Apr 19; 322(16):1098-105. PubMed ID: 2320079
    [Abstract] [Full Text] [Related]

  • 5. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P, Monnet I, Gherardi R.
    Ann Neurol; 1993 Oct 19; 34(4):561-5. PubMed ID: 8215243
    [Abstract] [Full Text] [Related]

  • 6. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R.
    Ann Neurol; 1991 Jun 19; 29(6):606-14. PubMed ID: 1892364
    [Abstract] [Full Text] [Related]

  • 7. [Myopathy and zidovudine].
    Mateo O, Gato A, Ballesteros P, Benito L, Pontes MJ, Esquinas G.
    Enferm Infecc Microbiol Clin; 1992 Oct 19; 10(8):474-6. PubMed ID: 1489776
    [Abstract] [Full Text] [Related]

  • 8. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
    Semino-Mora MC, Leon-Monzon ME, Dalakas MC.
    Lab Invest; 1994 Jul 19; 71(1):102-12. PubMed ID: 7518879
    [Abstract] [Full Text] [Related]

  • 9. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
    Lebrecht D, Deveaud C, Beauvoit B, Bonnet J, Kirschner J, Walker UA.
    Arthritis Rheum; 2008 Jan 19; 58(1):318-26. PubMed ID: 18163507
    [Abstract] [Full Text] [Related]

  • 10. Type B lactic acidosis in an AIDS patient treated with zidovudine.
    Aggarwal A, al-Talib K, Alabrash M.
    Md Med J; 1996 Nov 19; 45(11):929-31. PubMed ID: 8942169
    [Abstract] [Full Text] [Related]

  • 11. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
    Herzberg NH, Zorn I, Zwart R, Portegies P, Bolhuis PA.
    Muscle Nerve; 1992 Jun 19; 15(6):706-10. PubMed ID: 1324428
    [Abstract] [Full Text] [Related]

  • 12. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells.
    d'Amati G, Lewis W.
    Lab Invest; 1994 Dec 19; 71(6):879-84. PubMed ID: 7528833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA.
    Kärppä M, Herva R, Moslemi AR, Oldfors A, Kakko S, Majamaa K.
    Brain; 2005 Aug 19; 128(Pt 8):1861-9. PubMed ID: 15857931
    [Abstract] [Full Text] [Related]

  • 15. Analysis of myopathy in a placebo-controlled zidovudine trial.
    Simpson DM, Slasor P, Dafni U, Berger J, Fischl MA, Hall C.
    Muscle Nerve; 1997 Mar 19; 20(3):382-5. PubMed ID: 9052824
    [No Abstract] [Full Text] [Related]

  • 16. Muscle carnitine deficiency associated with zidovudine-induced mitochondrial myopathy.
    Campos Y, Arenas J.
    Ann Neurol; 1994 Oct 19; 36(4):680-1. PubMed ID: 7944307
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Zidovudine-associated myopathy.
    Paradis J, Calis KA.
    Am J Hosp Pharm; 1994 Dec 15; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract] [Full Text] [Related]

  • 19. Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
    Gherardi RK, Florea-Strat A, Fromont G, Poron F, Sabourin JC, Authier J.
    Ann Neurol; 1994 Nov 15; 36(5):752-8. PubMed ID: 7979221
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.